Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Pfizer
University of California, Davis
M.D. Anderson Cancer Center
Tempus AI
Checkpoint Therapeutics, Inc.